# Primaquine Enantiomers in G6PD Deficient Human Volunteers

> **NCT04073953** · PHASE1 · COMPLETED · sponsor: **University of Mississippi, Oxford** · enrollment: 18 (actual)

## Conditions studied

- G6PD Deficiency

## Interventions

- **DRUG:** RPQ
- **DRUG:** SPQ
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04073953
- **Lead sponsor:** University of Mississippi, Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-01
- **Primary completion:** 2023-09-01
- **Final completion:** 2023-09-01
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-11-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04073953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04073953, "Primaquine Enantiomers in G6PD Deficient Human Volunteers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04073953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*